Digital Pathology Market 2019 Trend, Future Growth, Leading Players Updates, Industry Demand, Current and Future Plans by Forecast to 2026

Published on: 23 August 2019

The Global Digital Pathology Market is likely to expand due to the rising use of advanced diagnostic tools for prompt diagnosis of chronic diseases. According to a report, titled “Digital Pathology: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to grow due to the increasing number of people diagnosed with related diseases.

Browse Complete Report Details @

https://www.fortunebusinessinsights.com/industry-reports/digital-pathology-market-100229

Use of Digital Pathology in Surgical Procedures Has Proven Hugely Beneficial

In surgical pathology, the diagnosed tissue can be detected, diagnosed, treated, and then incised into paper thin slices. These slices are then mounted upon glass slides, which are then examined by pathologists under microscopic conditions. This method was a first of its kind and possesses very high efficiency, besides offering clear and sharp images.

Sample PDF Brochure @

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/digital-pathology-market-100229

Some of the Main Key Players Covered in the Report

  • 3DHISTECH - The Digital Pathology Company
  • Mikroscan Technologies, Inc.
  • Objective Pathology Services
  • Hamamatsu Photonics
  • Roche Diagnostics Danmark
  • Primera Technology
  • Biogenuix Medsystems Pvt Ltd
  • Indica Labs
  • Philips Benelux
  • Inspirata
  • LigoLab LLC
  • Leica Biosystem
  • Olympus Corporation of the Americas
  • Nikon Optical Canada Inc.

FDA Clearance for Philips’ Intellisite Pathology to Bode Well for Digital Pathology Market

In April 2017, the FDA gave its approval to Philips’ Intellisite Pathology (PIPS) for manufacturing and sale in the U.S. This was the first ever digital pathology system in the market with FDA clearance. According to Fortune Business Insights, approval to Philips’ Intellisite will encourage other pathology device manufacturers to come up with their own patents and use PIPS as a reference.

Secondly, pathologists and related clinical centers that had held off buying any type of pathology systems, until they would receive clearance from a regulatory authority, would now willingly invest and buy Philips’ Intellisite due to the FDA approval. Such factors will lead to the entry of newer market players and also encourage existing companies to improvise as well as improve their product to shake off competition from Philips.

More Trending Topics from Fortune Business Insights:

Cardiovascular Stents Market 2019 Industry Size, Trends, Global Growth, Insights and Forecast Research Report 2025

Agricultural Pheromones Market 2019 | Top Leading Countries, Companies, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2025

 

This website uses cookies to ensure you get the best experience on our website.
Learn more